Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

NCT00191763 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell-Lung Cancer

Interventions

DRUG: Gemcitabine
DRUG: cisplatin

Sponsor

Eli Lilly and Company